Results 231 to 240 of about 9,364,795 (319)

Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation

JPGN Reports, EarlyView.
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant, Jenilee Pohle, Robert Tran, Roy Nattiv   +3 more
wiley   +1 more source

JAK Inhibitor and Crohn's Disease. [PDF]

Biomedicines
Xu M, Wang S, Xu S, Gong R.
europepmc   +1 more source

Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn’s disease [PDF]

, 2018
Ahmadian, Benowitz, Blumberg, Chen, Craig B. Wilen, Dermot P.B. McGovern, Feng Gao, Gabriel Nunez, Gerard E. Kaiko, Guo, Justin T. Kern, Kelli L. VanDussen, Liu, Liu, Michael J. Holtzman, Michael W. Rajala, Patel, Richard D. Head, Roberta Caruso, Shanshan Xiong, Ta-Chiang Liu, Thaddeus S. Stappenbeck   +21 more
core   +2 more sources

Efficacy of early treatment with infliximab in pediatric Crohn’s disease

, 2010
Jong Seung Lee
openalex   +2 more sources

Enteral Nutrition in Crohn’s Disease: An Underused Therapy [PDF]

, 2013
Sangeeta Kansal, Josef Wagner, Carl D. Kirkwood, Anthony G. Catto‐Smith   +3 more
openalex   +1 more source

Drug‐induced liver injury associated with selective androgen receptor modulators in an adolescent patient

JPGN Reports, EarlyView.
ABSTRACT Selective androgenic receptor modulators (SARMs) have similar properties to anabolic steroids but bind to androgen receptors in a tissue‐specific manner. Studies have investigated the benefits of SARMs in promoting bone and muscle growth while limiting the adverse effects of androgenic stimulation of other organs.
David J. Katibian, Laura E. Bauman, Katayoon Shayan, D. Brent Polk   +3 more
wiley   +1 more source

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease [PDF]

, 2015
Naoki Yoshimura, Yoko Yokoyama, Katsuyoshi Matsuoka, Hiroki Takahashi, Ryuichi Iwakiri, Takayuki Yamamoto, Tomoo Nakagawa, Takumi Fukuchi, Satoshi Motoya, Reiko Kunisaki, Shingo Kato, Fumihito Hirai, Yoh Ishiguro, Satoshi Tanida, Sakiko Hiraoka, Keiichi Mitsuyama, Shunji Ishihara, Shinji Tanaka, Michiro Otaka, Taro Osada, Takashi Kagaya, Yasuo Suzuki, Hiroshi Nakase, Hiroyuki Hanai, Kenji Watanabe, Nobuhito Kashiwagi, Toshifumi Hibi∥   +26 more
openalex   +1 more source

Posttraining survey of recent pediatric gastroenterology fellowship graduates

JPGN Reports, EarlyView.
Abstract Objectives The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Training Committee conducted a survey of recent fellowship graduates to assess their confidence in procedure performance, disease management, practice habits, and satisfaction with mentorship.
Christopher J. Moran, Christine K. Lee, Niviann Blondet, Rula Harb, Galen S. Hartman, Michael Herzlinger, Candi Jump, Priya S. Rolfes, Aliza Solomon, Arvind Srinath, Cary G. Sauer, Sarah S. Lusman, Daniel Mallon   +12 more
wiley   +1 more source

P983 Treatment of patients with moderate-to-severe Crohn’s disease with subcutaneous infliximab leads to an endoscopic response across all segments of the colon and terminal ileum: A post hoc analysis of the LIBERTY-CD study [PDF]

B E Sands, Marla C. Dubinsky, Geert D’Haens, S Schreiber, Silvio Danese, Stephen B. Hanauer, D H Kim, Y N Lee, Jean‐Frédéric Colombel   +8 more
openalex   +1 more source

Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease

Alimentary Pharmacology and Therapeutics, 2017
A. Yarur, Vikram S. Kanagala, D. Stein, Frank Czul, M. Quintero, D. Agrawal, Amir C. Patel, Kari Best, C. Fox, K. Idstein, M. Abreu   +10 more
semanticscholar   +1 more source